Related Experiment Video
Updated: Nov 13, 2025
![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
Published on: April 25, 2025
Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer
Bo Lin1, Qiujiao Wang1, Kun Liu1
1Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical College, Haikou, China.
Abstract:
Alpha-fetoprotein (AFP) entrance into cancer cells is mediated by AFP receptors (AFPRs) and exerts malignant effects. Therefore, understanding the structure of AFPRs will facilitate the development of rational approaches for vaccine design, drug delivery, antagonizing immune suppression and diagnostic imaging to treat cancer effectively. Throughout the last three decades, the identification of universal receptors for AFP has failed due to their complex carbohydrate polymer structures. Here, we focused on the two types of binding proteins or receptors that may serve as AFPRs, namely, the A) mucin receptors family, and B) the scavenger family. We presented an informative review with detailed descriptions of the signal transduction, cross-talk, and interplay of various transcription factors which highlight the downstream events following AFP binding to mucin or scavenger receptors. We mainly explored the underlying mechanisms involved mucin or scavenger receptors that interact with AFP, provide more evidence to support these receptors as tumor AFPRs, and establish a theoretical basis for targeting therapy of cancer.
Insights
Alpha-fetoprotein (AFP) binds to cancer cells via AFP receptors (AFPRs). This study reviews mucin and scavenger families as potential AFPRs, offering a basis for targeted cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Alpha-fetoprotein (AFP) mediates cancer cell entry through AFP receptors (AFPRs), contributing to malignancy.
- Understanding AFPR structure is crucial for developing cancer vaccines, drug delivery, and diagnostic imaging.
- Previous attempts to identify universal AFP receptors have been hindered by complex carbohydrate structures.
Purpose of the Study:
- To review and identify potential AFP receptors (AFPRs) within the mucin and scavenger receptor families.
- To explore the mechanisms of AFP interaction with these receptor families.
- To establish a theoretical foundation for targeting AFPRs in cancer therapy.
Main Methods:
- Literature review focusing on mucin and scavenger receptor families as potential AFPRs.
- Analysis of signal transduction pathways, receptor cross-talk, and transcription factor interplay.
- Examination of downstream events following AFP binding to identified receptors.
Main Results:
- Identification of mucin and scavenger receptor families as likely candidates for AFPRs.
- Detailed description of molecular mechanisms and signaling cascades involved in AFP-receptor interactions.
- Evidence supporting the role of these receptors in cancer progression.
Conclusions:
- The mucin and scavenger receptor families represent promising targets for cancer therapy.
- Understanding AFP-receptor interactions provides a basis for developing novel therapeutic strategies.
- Targeting AFPRs offers potential for improved cancer treatment outcomes.
More Related Videos
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:38Mitogens and the Cell Cycle